EPRO for Adjuvant Therapy of Colorectal Adenocarcinoma

ABSTRACT: It is a multi-centric randomized controlled trial. The goal of this study is to observe the improvement of QoL using ePRO to manage patients with colorectal cancer who received Oxaliplatin-based adjuvant chemotherapy.The prognosis will also be studied.

DISEASE(S): Colorectal Carcinoma,Colorectal Neoplasms

PROVIDER: 2314733 | ecrin-mdr-crc |

REPOSITORIES: ECRIN MDR